Reginald Motley, MS

Reginald has extensive experience in product lifecycle management from conceptual development through design development to industrialization and commercialization, focused on biologics, utilizing drug delivery systems and medical devices. Currently, Reginald is CMC Leader at Teva’s Specialty R&D Biologics, leading cross-functional product development teams on innovative and biosimilar products and product launches to the US and European markets.

•    Biopharma: Drug Delivery
•    Digital Health: Health IT
•    Devices & Instrumentation: Hardware – Consumer applications, Hardware – Industrial applications, Hardware – Biomedical
•    Other: Precision health, Drug delivery devices – Syringes, auto-injectors, wearables, Device design development; Human factors study design and execution